Cargando…
P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR MAGNETISMM-3
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430580/ http://dx.doi.org/10.1097/01.HS9.0000846664.78859.dd |
| _version_ | 1784779810767110144 |
|---|---|
| author | Lesokhin, A. M. Arnulf, B. Niesvizky, R. Mohty, M. Bahlis, N. J. Tomasson, M. H. Rodrίguez-Otero, P. Quach, H. Raje, N. S. Iida, S. Raab, M.-S. Czibere, A. Sullivan, S. Leip, E. Viqueira, A. Leleu, X. |
| author_facet | Lesokhin, A. M. Arnulf, B. Niesvizky, R. Mohty, M. Bahlis, N. J. Tomasson, M. H. Rodrίguez-Otero, P. Quach, H. Raje, N. S. Iida, S. Raab, M.-S. Czibere, A. Sullivan, S. Leip, E. Viqueira, A. Leleu, X. |
| author_sort | Lesokhin, A. M. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430580 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94305802022-08-31 P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR MAGNETISMM-3 Lesokhin, A. M. Arnulf, B. Niesvizky, R. Mohty, M. Bahlis, N. J. Tomasson, M. H. Rodrίguez-Otero, P. Quach, H. Raje, N. S. Iida, S. Raab, M.-S. Czibere, A. Sullivan, S. Leip, E. Viqueira, A. Leleu, X. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430580/ http://dx.doi.org/10.1097/01.HS9.0000846664.78859.dd Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Lesokhin, A. M. Arnulf, B. Niesvizky, R. Mohty, M. Bahlis, N. J. Tomasson, M. H. Rodrίguez-Otero, P. Quach, H. Raje, N. S. Iida, S. Raab, M.-S. Czibere, A. Sullivan, S. Leip, E. Viqueira, A. Leleu, X. P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR MAGNETISMM-3 |
| title | P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR MAGNETISMM-3 |
| title_full | P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR MAGNETISMM-3 |
| title_fullStr | P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR MAGNETISMM-3 |
| title_full_unstemmed | P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR MAGNETISMM-3 |
| title_short | P949: A PHASE 2 TRIAL OF ELRANATAMAB, A B-CELL MATURATION ANTIGEN (BCMA)-CD3 BISPECIFIC ANTIBODY, IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: INITIAL SAFETY RESULTS FOR MAGNETISMM-3 |
| title_sort | p949: a phase 2 trial of elranatamab, a b-cell maturation antigen (bcma)-cd3 bispecific antibody, in patients with relapsed/refractory multiple myeloma: initial safety results for magnetismm-3 |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430580/ http://dx.doi.org/10.1097/01.HS9.0000846664.78859.dd |
| work_keys_str_mv | AT lesokhinam p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT arnulfb p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT niesvizkyr p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT mohtym p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT bahlisnj p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT tomassonmh p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT rodriguezoterop p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT quachh p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT rajens p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT iidas p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT raabms p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT cziberea p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT sullivans p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT leipe p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT viqueiraa p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 AT leleux p949aphase2trialofelranatamababcellmaturationantigenbcmacd3bispecificantibodyinpatientswithrelapsedrefractorymultiplemyelomainitialsafetyresultsformagnetismm3 |